Environmental campaigners are protesting that a new patent acquired by
Monsanto could stifle scientific research. The patent, granted in the US in
January, is for the insertion of antibiotic resistance genes as markers during
experiments. Rural Advancement Foundation International, a lobby group based in
Canada, says that the patent will enable Monsanto to charge researchers to use a
common tool in genetic engineering. The company denies this, saying it has
allowed free use since it first invented the technology 18 years ago.
To continue reading, today with our introductory offers
Advertisement
More from New ÒÁÈ˾þÃ
Explore the latest news, articles and features
Life
Himalayan wolf-dog hybrids emerge as a threat to wolves and people
News
Environment
First test of CO2 removal with green sand finds no harm to marine life
News
Space
SpaceX is about to launch tallest and most powerful rocket in history
News
Environment
Cleaning up air pollution could weaken vital AMOC ocean current
News
Popular articles
Trending New ÒÁÈ˾þà articles
1
A new tectonic plate boundary could be forming in southern Africa
2
SpaceX is about to launch tallest and most powerful rocket in history
3
Where did the laws of physics come from? I think I've found the answer
4
First test of CO2 removal with green sand finds no harm to marine life
5
Vocal fry is more common in men, actually, find scientists
6
Himalayan wolf-dog hybrids emerge as a threat to wolves and people
7
Why autism pioneer Uta Frith wants to dismantle the spectrum
8
CAR T-cell therapy bolstered by stiffening up cancer cells first
9
PCOS has been officially renamed PMOS, and it’s a momentous move
10
Dead Sea Scrolls analysis may force rethink of ancient Jewish history
